Mucosal Healing Is Associated with Improved Long-term Outcome of Maintenance Therapy with Natalizumab in Crohnʼs Disease

Natalizumab in Crohn’s Disease

(2013) Atsushi Sakuraba et al.   INFLAMMATORY BOWEL DISEASES

Vedolizumab for the treatment of ulcerative colitis and Crohn’s disease

(2012) Leon P McLean et al.   Immunotherapy

Natalizumab for moderate to severe Crohnʼs disease in clinical practice: The Mayo Clinic Rochester experience

(2012) S. V. Kane et al.   INFLAMMATORY BOWEL DISEASES

A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy and Hospitalization

(2010) Abderrahim Oussalah et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Th1/Th17 Immune Response Is Induced by Mesenteric Lymph Node Dendritic Cells in Crohn's Disease

(2009) Atsushi Sakuraba et al.   GASTROENTEROLOGY

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease

(2009) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES